NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

醫療輻射屏蔽產品的全球市場:增長,趨勢,預測(2020-2025)

Medical Radiation Shielding Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 964920
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
醫療輻射屏蔽產品的全球市場:增長,趨勢,預測(2020-2025) Medical Radiation Shielding Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年08月01日內容資訊: 英文 110 Pages
簡介

在預測期內,醫療輻射防護產品的市場規模預計將以約4.6%的複合年增長率增長。

推動市場增長的特殊因素包括:越來越多地使用核醫學和放射療法進行診斷和治療;癌症的發病率增加;以及在容易發生輻射的環境中工作的人們的安全意識。包括改進。

根據世界癌症日的一份報告,癌症的發病率將再增加50%,到2020年可能有1500萬新病例。該報告還提供了明確的證據,表明政府和醫護人員的健康生活方式和公共衛生活動可以阻止這一趨勢,並預防全世界三分之一的癌症。

美國癌症統計和數據領先機構美國癌症協會(American Cancer Society)報告稱,2016年美國估計有1,685,210例新癌症病例和595,690例癌症死亡。

美國國家癌症研究所報告說,全世界60%以上的新癌症病例都發生在非洲,亞洲以及中南美洲。世界上70%的癌症死亡病例也發生在這些地區。根據國際癌症研究組織(IARC)的研究,除了吸煙,飲食習慣不良,缺乏體育鍛煉以及經濟發展中國家的出生減少等因素外,這還僅僅是由於全球人口增長和老齡化所致。到2030年,預計負擔將增加到2170萬新癌症病例和1300萬癌症死亡。

根據世界衛生組織的數據,將近70%的癌症死亡發生在中低收入國家,並且有五個中低收入國家擁有推動癌症政策所需的數據。每個國家只有一個國家。對於新的癌症治療方法而言,這種全球性和廣泛的癌症威脅仍然是主要的市場增長因素,可幫助風險評估,早期診斷和有效監測治療方法。

該報告調查了醫療輻射防護產品的全球市場,提供了市場概況,按解決方案,產品,最終用戶和地區分析了市場增長和障礙,市場機會以及市場規模趨勢。它提供了系統的信息,例如預測,競爭條件和主要公司的概況。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 市場驅動力
    • 核醫學用於診斷和治療,以及放射治療的更多使用
    • 癌症發病率增加
    • 提高了在可能發生輻射的環境中工作的人員的安全意識
  • 市場限制
    • 缺乏熟練的輻射專家
    • 成本高,贖回率降低
  • 波特的五力分析

第5章市場細分

  • 通過解決方案
    • 輻射屏蔽
    • 診斷屏蔽
  • 副產品
    • 建築材料
    • 可穿戴
    • 其他
  • 最終用戶
    • 醫院和診斷中心
    • 研究機構
    • 其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲

第6章競爭情況

  • 公司簡介
    • A&L Shielding
    • Amray Medical
    • ETS-Lindgren
    • Gaven Industries Inc.
    • Global Partners in Shielding Inc.
    • Marshield
    • Nelco Inc.
    • Radiation Protection Products Inc.
    • Ray-Bar Engineering Corp.
    • Veritas Medical Solutions LLC

第7章 市場機會與動向

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 68422

The medical radiation shielding market studied is anticipated to witness a CAGR of nearly 4.6%, during the forecast period.

Certain factors driving the market growth include increasing usage of nuclear medicine and radiation therapy for diagnosis and treatment, rising incidences of cancer, and growing safety awareness among people working in radiation-prone environments.

Cancer rates could further increase by 50%, to 15 million new cases by2020, as per the World Cancer Report. It also provides clear evidence that healthy lifestyles and public health action by governments and health practitioners could stem this trend, and prevent as many as one-third of cancers, worldwide.

The American Cancer Society, the leading body in cancer stats and figures, reports 1,685,210 estimated new cancer cases and 595,690 deaths due to cancer in 2016, in the United States.

The National Cancer Institute reports that more than 60% of the world's new cancer cases occur in Africa, Asia, and Central and South America; 70% of the world's cancer deaths also occur in these regions. The International Agency for Research on Cancer (IARC) predicts that by 2030, the global burden is expected to rise to 21.7 million new cancer cases and 13 million cancer deaths, simply due to growth and aging of the population, leaving aside factors, such as smoking, poor diet, physical inactivity, and fewer childbirths in economically developing countries.

According to WHO, almost 70% of deaths from cancer occur in low- and middle-income countries, and only one in five low- and middle-income countries has the necessary data to drive cancer policy. This global and extensive threat of cancer remains a major market driver for new cancer therapies that help in risk assessment, early diagnosis, and effective monitoring of the treatment.

Key Market Trends

Diagnostic Shielding Holds Significant Share in the Global Medical Radiation Shielding Market

Medical imaging has witnessed numerous advancements in recent times. The emerging technologies help in enhancing the resolution and quality of the medical images. The development of a new and compact superconducting magnet can improve MRI applications soon. Moreover, MRI systems are getting better every day. Recently developed MRI systems with power equivalent to 150,000 times Earth's magnetic field can produce images in greater detail than standard cardiac images. These technological advancements in medical imaging will promote the usage of the PET, SPECT, and other diagnostic devices that are likely to drive the market over the forecast period.

The healthy growth of the nuclear imaging market is evident with new technologies introduced every year. Radioisotopes are an integral part of medical diagnostic procedures. Combined with imaging devices, which register the gamma rays emitted from within, these isotopes can study the dynamic processes taking place in various parts of the body.

Advanced imaging technologies have increased the diagnostic yield for the detection of a number of diseases that were earlier difficult to diagnose, especially during the early stages of disease pathology. Thus, increasing medical imaging is expected to drive the growth of the concerned segment of the market.

North America Dominates the Medical Radiation Shielding Market

In the North American region, the United States accounted for the largest market share. In 2016, the AMIPA (American Medical Isotope Production Act) and the DOE/NNSA (Department of Energy) established a Uranium Lease and Take-Back (ULTB) program in the United States. Under this program, the DOE/NNSA makes LEU (Low Enriched Uranium) available through lease contracts for the irradiation and production of Mo99 for medical uses. The AMIPA not only promotes the domestic production of Mo-99, but it also aims to replace the role of HEU (High Enriched Uranium) in the production of medical radioactive isotopes.

Furthermore, Canada is a long-standing leader in the field of nuclear imaging. The technology is found to be used by the researchers in applications of cardiology, oncology, and neurology, as well as musculoskeletal imaging, ophthalmology, dermatology, and dentistry. Canada is one of the largest producers of Technetium-99m. With the use of Tc-99m in radiopharmaceuticals, the market is expected to grow at a tremendous rate in Canada. It is also combined with a variety of biologically active molecules to perform non-invasive, real-time imaging of the human body.

In Mexico, there has been an increasing awareness among people about nuclear medicine treatment and diagnosis, which, in turn, has increased the need for radiation shielding. This is expected to trigger the growth of the market.

Competitive Landscape

The medical radiation shielding market is competitive and consists of a few major players. Companies like A&L Shielding, Amray Medical, ETS-Lindgren, Gaven Industries, Inc., Global Partners in Shielding Inc., MarShield, Nelco Inc., Radiation Protection Products Inc., Ray-Bar Engineering Corp., and Veritas Medical Solutions LLC, among others, hold the substantial market share in the market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Usage of Nuclear Medicine and Radiation Therapy for Diagnosis and Treatment
    • 4.2.2 Rising Incidences of Cancer
    • 4.2.3 Growing Safety Awareness Among People Working in Radiation-prone Environments
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Radiation Professionals
    • 4.3.2 High Cost and Declining Reimbursement Rates
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Solution
    • 5.1.1 Radiation Therapy Shielding
    • 5.1.2 Diagnostic Shielding
  • 5.2 By Product
    • 5.2.1 Building/Construction Materials
    • 5.2.2 Wearable
    • 5.2.3 Other Products
  • 5.3 By End User
    • 5.3.1 Hospitals and Diagnostic Centers
    • 5.3.2 Research Institutes
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 A&L Shielding
    • 6.1.2 Amray Medical
    • 6.1.3 ETS-Lindgren
    • 6.1.4 Gaven Industries Inc.
    • 6.1.5 Global Partners in Shielding Inc.
    • 6.1.6 Marshield
    • 6.1.7 Nelco Inc.
    • 6.1.8 Radiation Protection Products Inc.
    • 6.1.9 Ray-Bar Engineering Corp.
    • 6.1.10 Veritas Medical Solutions LLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS